Non-Small Cell Lung Cancer [clinicaltrials_resource:ab14773ed54a09fa58d253c460bc3881]
ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00034346]Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer [clinicaltrials:NCT00051974]Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer [clinicaltrials:NCT00062907]A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer [clinicaltrials:NCT00073151]Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer [clinicaltrials:NCT00073723]A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer [clinicaltrials:NCT00078260]A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients [clinicaltrials:NCT00085826]clinicaltrials:NCT00085839Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00094822]clinicaltrials:NCT00094835clinicaltrials:NCT00094861clinicaltrials:NCT00102804Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy [clinicaltrials:NCT00115206]Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy [clinicaltrials:NCT00120679]clinicaltrials:NCT00130728Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer [clinicaltrials:NCT00150657]Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00154739]SERPIN D1 and Its Role in Lung Cancer Invasion and Metastasis [clinicaltrials:NCT00155116]PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00173524]Methylation Status of CD44 Promoter Region in Primary Lung Cancer [clinicaltrials:NCT00173680]Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer [clinicaltrials:NCT00173875]Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00176137]clinicaltrials:NCT00178698A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer [clinicaltrials:NCT00179686]Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer [clinicaltrials:NCT00179699]A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer [clinicaltrials:NCT00190710]Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Early Stages NSCLC [clinicaltrials:NCT00191126]clinicaltrials:NCT00191308Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00198367]Follow-up of Patients With Curative-Intent Surgical Resection for NSCLC [clinicaltrials:NCT00199615]NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine [clinicaltrials:NCT00199849]Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer [clinicaltrials:NCT00200382]Phs. II Study of OSI-774 (Erlotinib, Tarceva) in Elderly Patients W/Advanced Stage or Inoperable Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00200395]Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients [clinicaltrials:NCT00211952]clinicaltrials:NCT00216125clinicaltrials:NCT00216203Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer [clinicaltrials:NCT00217282]Role of PET CT in Determining Target Volumes in Radiation Therapy for Lung Cancer [clinicaltrials:NCT00221169]clinicaltrials:NCT00231465clinicaltrials:NCT00240097
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Non-Small Cell Lung Cancer [clinicaltrials_resource:ab14773ed54a09fa58d253c460bc3881]
Bio2RDF identifier
ab14773ed54a09fa58d253c460bc3881
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ab14773ed54a09fa58d253c460bc3881
identifier
clinicaltrials_resource:ab14773ed54a09fa58d253c460bc3881
title
Non-Small Cell Lung Cancer
@en
label
Non-Small Cell Lung Cancer [clinicaltrials_resource:ab14773ed54a09fa58d253c460bc3881]
@en